AlHilli Mariam, Langstraat Carrie, Tran Christine, Martin Janice, Weaver Amy, McGree Michaela, Mariani Andrea, Cliby William, Bakkum-Gamez Jamie
*Division of Gynecologic Surgery, Department of Obstetrics and Gynecology; †Mayo Medical School; ‡Surgery Research; and §Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN.
Int J Gynecol Cancer. 2015 Feb;25(2):193-202. doi: 10.1097/IGC.0000000000000339.
To identify patients at risk for postoperative morbidities, we evaluated indications and factors associated with 30-day readmission after epithelial ovarian cancer surgery.
Patients undergoing primary surgery for epithelial ovarian cancer between January 2, 2003, and December 29, 2008, were evaluated. Univariable and multivariable logistic regression models were fit to identify factors associated with 30-day readmission. A parsimonious multivariable model was identified using backward and stepwise variable selection.
In total, 324 (60.2%) patients were stage III and 91 (16.9%) were stage IV. Of all 538 eligible patients, 104 (19.3%) were readmitted within 30 days. Cytoreduction to no residual disease was achieved in 300 (55.8%) patients, and 167 (31.0%) had measurable disease (≤1 cm residual disease). The most common indications for readmission were surgical site infection (SSI; 21.2%), pleural effusion/ascites management (14.4%), and thromboembolic events (12.5%). Multivariate analysis identified American Society of Anesthesiologists score of 3 or higher (odds ratio, 1.85; 95% confidence interval, 1.18-2.89; P = 0.007), ascites [1.76 (1.11-2.81); P = 0.02], and postoperative complications during initial admission [grade 3-5 vs none, 2.47 (1.19-5.16); grade 1 vs none, 2.19 (0.98-4.85); grade 2 vs none, 1.28 (0.74-2.21); P = 0.048] to be independently associated with 30-day readmission (c-index = 0.625). Chronic obstructive pulmonary disease was the sole predictor of readmission for SSI (odds ratio, 3.92; 95% confidence interval, 1.07-4.33; P = 0.04).
Clinically significant risk factors for 30-day readmission include American Society of Anesthesiologists score of 3 or higher, ascites and postoperative complications at initial admission. The SSI and pleural effusions/ascites are common indications for readmission. Systems can be developed to predict patients needing outpatient management, improve care, and reduce costs.
为了确定有术后发病风险的患者,我们评估了上皮性卵巢癌手术后30天再入院的相关指征和因素。
对2003年1月2日至2008年12月29日期间接受上皮性卵巢癌初次手术的患者进行评估。采用单变量和多变量逻辑回归模型来确定与30天再入院相关的因素。使用向后和逐步变量选择方法确定一个简约的多变量模型。
总共有324例(60.2%)患者为Ⅲ期,91例(16.9%)为Ⅳ期。在所有538例符合条件的患者中,104例(19.3%)在30天内再次入院。300例(55.8%)患者实现了肿瘤细胞减灭至无残留病灶,167例(31.0%)有可测量病灶(残留病灶≤1 cm)。再入院最常见的指征是手术部位感染(SSI;21.2%)、胸腔积液/腹水管理(14.4%)和血栓栓塞事件(12.5%)。多变量分析确定美国麻醉医师协会评分为3分或更高(比值比,1.85;95%置信区间,1.18 - 2.89;P = 0.007)、腹水[1.76(1.11 - 2.81);P = 0.02]以及初次入院时的术后并发症[3 - 5级与无并发症相比,2.47(1.19 - 5.16);1级与无并发症相比,2.19(0.98 - 4.85);2级与无并发症相比,1.28(0.74 - 2.21);P = 0.048]与30天再入院独立相关(c指数 = 0.625)。慢性阻塞性肺疾病是SSI再入院的唯一预测因素(比值比,3.92;95%置信区间,1.07 - 4.33;P = 0.04)。
30天再入院的具有临床意义的危险因素包括美国麻醉医师协会评分为3分或更高、腹水以及初次入院时的术后并发症。SSI和胸腔积液/腹水是再入院的常见指征。可以开发相关系统来预测需要门诊管理的患者,改善护理并降低成本。